Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Controlled Human Malaria Infection of Healthy Adults With Lifelong Malaria Exposure to Assess Safety, Immunogenicity, and Efficacy of the Asexual Blood Stage Malaria Vaccine Candidate GMZ2
Jean Claude Dejon‐Agobé, Ulysse Ateba-Ngoa, Albert Lalremruata, et al.
Clinical Infectious Diseases (2018) Vol. 69, Iss. 8, pp. 1377-1384
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination
Angela M. Minassian, Sarah E. Silk, Jordan R. Barrett, et al.
Med (2021) Vol. 2, Iss. 6, pp. 701-719.e19
Open Access | Times Cited: 122
A review of criteria strictness in “Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials”
Motoki Amai, Masanori Nojima, Yoshikazu Yuki, et al.
Vaccine (2023) Vol. 41, Iss. 38, pp. 5622-5629
Open Access | Times Cited: 108
Current Status of Malaria Control and Elimination in Africa: Epidemiology, Diagnosis, Treatment, Progress and Challenges
Jiahuan Li, Haragakiza Jean Docile, David Fisher, et al.
Journal of Epidemiology and Global Health (2024) Vol. 14, Iss. 3, pp. 561-579
Open Access | Times Cited: 18
Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites
Roos M. de Jong, Surafel K. Tebeje, Lisette Meerstein‐Kessel, et al.
Immunological Reviews (2019) Vol. 293, Iss. 1, pp. 190-215
Open Access | Times Cited: 82
Malaria Vaccines: Progress to Date
Danielle I. Stanisic, Michael F. Good
BioDrugs (2023) Vol. 37, Iss. 6, pp. 737-756
Open Access | Times Cited: 34
Sporozoite immunization: innovative translational science to support the fight against malaria
Thomas L. Richie, L. W. Preston Church, Tooba Murshedkar, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 964-1007
Open Access | Times Cited: 27
Host-parasite interactions during Plasmodium infection: Implications for immunotherapies
Pankaj Chandley, Ravikant Ranjan, Sudhir Kumar, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 24
The impact of Plasmodium-driven immunoregulatory networks on immunity to malaria
Michelle J. Boyle, Christian Engwerda, Prasanna Jagannathan
Nature reviews. Immunology (2024) Vol. 24, Iss. 9, pp. 637-653
Closed Access | Times Cited: 8
Immunogenicity and Protective Efficacy of Radiation-Attenuated and Chemo-Attenuated PfSPZ Vaccines in Equatoguinean Adults
Said Jongo, Vicente Urbano, L. W. Preston Church, et al.
American Journal of Tropical Medicine and Hygiene (2020) Vol. 104, Iss. 1, pp. 283-293
Open Access | Times Cited: 56
Toxin expression during Staphylococcus aureus infection imprints host immunity to inhibit vaccine efficacy
Omid Teymournejad, Zhaotao Li, Pavani Beesetty, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 19
Malaria vaccine efficacy, safety, and community perception in Africa: a scoping review of recent empirical studies
Muhammad Chutiyami, Priya Saravanakumar, Umar Muhammad Bello, et al.
Infection (2024) Vol. 52, Iss. 5, pp. 2007-2028
Open Access | Times Cited: 6
Advances in Vaccine Development for Chlamydia trachomatis
Taylor B. Poston
Pathogens and Disease (2024) Vol. 82
Open Access | Times Cited: 6
Controlled Human Infection Models To Accelerate Vaccine Development
Robert K. M. Choy, A. Louis Bourgeois, Christian F. Ockenhouse, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 25
Interdisciplinary symposium on challenges and opportunities for vaccines: A comprehensive approach of current and future vaccine strategies to improve vaccine effectiveness in complex chronic infectious contexts
Alex S. Siebner, Marrium Habib, Vanesa Osmani, et al.
Vaccine X (2025), pp. 100615-100615
Open Access
Serologic Markers of Previous Malaria Exposure and Functional Antibodies Inhibiting Parasite Growth Are Associated With Parasite Kinetics Following a Plasmodium falciparum Controlled Human Infection
Jane Achan, Isaie J. Reuling, Xi Zen Yap, et al.
Clinical Infectious Diseases (2019) Vol. 70, Iss. 12, pp. 2544-2552
Open Access | Times Cited: 38
Recombinase Polymerase Amplification and Lateral Flow Assay for Ultrasensitive Detection of Low-Density Plasmodium falciparum Infection from Controlled Human Malaria Infection Studies and Naturally Acquired Infections
Albert Lalremruata, Nguyen Trong The, Matthew B. B. McCall, et al.
Journal of Clinical Microbiology (2020) Vol. 58, Iss. 5
Open Access | Times Cited: 36
Correlates of malaria vaccine efficacy
Danielle I. Stanisic, Matthew B. B. McCall
Expert Review of Vaccines (2021) Vol. 20, Iss. 2, pp. 143-161
Open Access | Times Cited: 30
PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial
Francisco José Martínez Martínez, Michael White, Micheline Guillotte-Blisnick, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
A systematic review on malaria and Tuberculosis (TB) vaccine challenges in sub-Saharan African clinical trials
Maonezi Abas Hamisi, Nur Atikah Mohd Asri, Aini Syahida Mat Yassim, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0317233-e0317233
Open Access
In vitro evaluation of multi-protein chimeric antigens in effectively clearing the blood stage of Plasmodium falciparum
Bhagyashree Deshmukh, Dhruv Khatri, Sanjay Kumar Kochar, et al.
Vaccine (2025) Vol. 53, pp. 126952-126952
Closed Access
Immunosuppression in Malaria: Do Plasmodium falciparum Parasites Hijack the Host?
Carlos Lamsfus Calle, Benjamin Mordmüller, Anurag Singh
Pathogens (2021) Vol. 10, Iss. 10, pp. 1277-1277
Open Access | Times Cited: 26
A Reproducible and Scalable Process for Manufacturing a Pfs48/45 Based Plasmodium falciparum Transmission-Blocking Vaccine
Susheel Kumar Singh, Jordan Plieskatt, Bishwanath Kumar Chourasia, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 25
BpOmpW antigen administered with CAF01 adjuvant stimulates comparable T cell responses to Sigma adjuvant system
Julen Tomás‐Cortázar, Conor Quinn, Niamh Corcoran, et al.
Vaccine X (2024) Vol. 17, pp. 100438-100438
Open Access | Times Cited: 3
Development of sustainable research excellence with a global perspective on infectious diseases: Centre de Recherches Médicales de Lambaréné (CERMEL), Gabon
Michael Ramharter, Selidji Todagbé Agnandji, Ayôla Akim Adégnika, et al.
Wiener klinische Wochenschrift (2021) Vol. 133, Iss. 9-10, pp. 500-508
Open Access | Times Cited: 22
Prime-Pull Immunization with a Bivalent M-Protein and Spy-CEP Peptide Vaccine Adjuvanted with CAF®01 Liposomes Induces Both Mucosal and Peripheral Protection from covR/S Mutant Streptococcus pyogenes
Victoria Ozberk, Simone Reynolds, Yongbao Huo, et al.
mBio (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top